Who's next in weight loss: Reuters rounds up the obesity drug pipeline
A Reuters factbox lists the drugs chasing Wegovy and Mounjaro, including Novo's amycretin and CagriSema, Lilly's retatrutide and EloraTZP, Pfizer's monthly PF-3944 and pills from AstraZeneca, Structure and Merck. Analysts expect the weight-loss market to reach about $100 billion in annual sales within a decade.
Image credit: Reuters via Investing.com
Source: Reuters via Investing.com (16 Oct 2026).